Parr v. Rosenthal
57 N.E.3d 947
Mass.2016Background
- In Nov. 2005 Dr. Daniel Rosenthal performed a radio‑frequency ablation (RFA) on eight‑year‑old William Parr at MGH; the procedure caused a severe burn that ultimately required two amputations.
- Rosenthal stopped the procedure when he observed a burn; he visited William during hospitalization but his direct treatment role ended by December 2005.
- William continued to receive treatment from other sarcoma‑group physicians (Drs. Raskin and Ebb) who performed debridements and ultimately amputations in 2006 and 2008.
- Parents filed suit for medical malpractice on March 9, 2009. The defendant moved for judgment as time‑barred under the three‑year statute of limitations (G. L. c. 231, § 60D for minors ≥6).
- Trial judge instructed the jury using the discovery rule (accrual when plaintiff knows or reasonably should know of harm and likely cause) and declined to give a “continuing treatment” instruction; the jury found plaintiffs knew or should have known by March 6, 2006, so it did not reach negligence.
- Appeals Court adopted a continuing treatment rule and remanded; the Supreme Judicial Court granted further review and addressed whether Massachusetts should recognize the continuing treatment doctrine and its scope.
Issues
| Issue | Plaintiff's Argument (Parr) | Defendant's Argument (Rosenthal) | Held |
|---|---|---|---|
| Whether Massachusetts should recognize the continuing treatment doctrine tolling accrual while physician continues to treat for same/related condition | Court should adopt doctrine so statute doesn’t run while patient reasonably relies on treating physician and allows corrective efforts | Adoption would be judicial overreach; Legislature’s silence implies rejection and policy/cost concerns favor maintaining current accrual rule | SJC adopts continuing treatment doctrine: statute of limitations generally tolled while physician‑patient relationship continues for same/related injury, as common‑law accrual rule |
| When tolling under continuing treatment ends | Tolling should continue so long as patient continues treatment in good faith even if aware of harm | Tolling should end when patient actually knows of appreciable harm (or legislative policy should control) | Tolling ends only when patient has actual knowledge that physician’s negligence (not merely a complication) caused the appreciable harm |
| Whether treatment by other physicians in same group or team tolls accrual for claim against initial physician | Tolling should extend while other members of same treatment team or group continue to treat (imputing group treatment) | Continuing treatment doctrine should not be extended beyond the defendant’s own treatment or active supervision/consultation | Tolling may apply where defendant continues to supervise/advise/consult; court declines to extend doctrine broadly to loosely defined “treatment teams” absent proof patient was a group/clinic patient or defendant maintained control |
| Effect on this case (timeliness) | Jury should have been instructed on continuing treatment; accrual tolled through later care by sarcoma team | Rosenthal’s treatment role ended Dec. 2005; plaintiffs had actual/constructive knowledge >3 years before suit | Because jury found plaintiffs knew or reasonably should have known by March 2006 and Rosenthal’s direct role ended by Dec. 2005, claim accrued >3 years before suit; judgment for defendant affirmed |
Key Cases Cited
- Murphy v. Smith, 411 Mass. 133 (1991) (adopting continuing‑representation tolling in legal malpractice)
- Franklin v. Albert, 381 Mass. 611 (1980) (discovery rule applies to medical malpractice accrual)
- Bowen v. Eli Lilly & Co., 408 Mass. 204 (1990) (accrual does not require notice of breach; notice of likely cause suffices)
- Lyons v. Nutt, 436 Mass. 244 (2002) (continuing‑representation tolling ends on actual knowledge of appreciable harm)
- Borgia v. New York, 12 N.Y.2d 151 (1962) (illustrative formulation of continuing treatment doctrine in medical malpractice)